French wine originates from Italy?
Wine is enjoyed worldwide, with France renowned as a top producer. However, the earliest known biomolecular evidence of grape wine and winemaking has been presented in the Proceedings of the National Academy of Sciences (PNAS)1
Liquid chromatography coupled to orbitrap mass spectrometry was used to analyse ancient wine and grape samples.
Wine is enjoyed worldwide, with France renowned as a top producer. However, the earliest known biomolecular evidence of grape wine and winemaking has been presented in the Proceedings of the National Academy of Sciences (PNAS)1, indicating that the origins of French viniculture lie in Italy.
Etruscan amphoras (pottery vessels) dating back to around500 B.C. and known to have been imported to France fromItaly were selected for investigation. Specimens were selected that showed evidence of liquid residues, appeared whole and unwashed, and that had not been previously disturbed.
Dr Patrick McGovern, Director of the BiomolecularArchaeology Laboratory at the University of PennsylvaniaMuseum of Archaeology and Anthropology (Pennsylvania,USA), worked in collaboration with colleagues from Franceand the USA to chemically analyse residues adsorbed to thepottery fabric.
Sample extraction was performed first, followed byinfrared spectrometry (IRS), solid-phase microextraction(SPME), and ultrahigh-performance liquid chromatographytandem mass spectrometry (UHPLC–MS). Residues extractedfrom the amphoras identified positively for tartaric acid andtartarate, biomarkers for Eurasian grape and wine in theMiddle East and Mediterranean.
Reference
1. P. McGovern et al, PNAS, DOI:10.1073/pnas.1216126110 (2013).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
